Charles Schwab Investment Management Inc. Raises Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)
Charles Schwab Investment Management Inc. raised its holdings in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) by 20.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 353,038 shares of the company’s stock after buying an additional 60,178 shares during […]
